Dedicated in R&D,production and marketing of special API and intermediates,Rongda Pharm & Chem Co.,Ltd has established markets to USA,EU region,ASEAN countries,etc with its experienced technocrats as core. Started business in the year of 2003,until now more than 200 initiative Rongda people, among which 115 people has got well colleage degree, grow with the company, who has well established organisational structure,including R&D,production,QA,etc.
With rapid development of the company,we have two exhisted plants locatded in Anhui and Jiangxi province,and one more new plant is under constructed in Jiangxi for future project. Our Jiangxi plant occupied 32,000 m2 area,it has 5 workshops .Tens of glass-lined reactors with volume ranged from 200L to 3000L ,which can satify different reaction conditions.Moreover,our Anhui site currently is dedicated in production of pharm intermediates.Concerning to QC test,we have equiped with different types of analytical intruments which can meet different test requirements.
Our business has been separated into two parts,including marketing of our own API and intermediates as well as CRAMs (contract research and manufacturings). Great efforts has been made by Rongda people on the development of API,that we have focused on the development of anticancer products,and take cardiovascular & antidepressant series as our strategic developmet products . In addition,we have successfully expanded our business of Anastrozole,Letrozole ,Lapatinib, Ibandronate sodium,Fulvestrant, Palonsetron HCl,Sorafenib,etc to some top 30 pharm giants. Moreover,with the clear trend of pharmaceutical manufacturing transfer from western countries to India and China, Rongda pharm strategically step into business of CRAMs,for which we have tens of experienced R&D scientists to support. With the principle of 'to be honest,quality first,credit as our life", we will always try our best to provide our customer first class products and services .Warmly welcome friends from both domestic and abroad to cooperate with us.
